|
Volumn 37, Issue 7, 2005, Pages 3098-3100
|
Is HLA-DR6 a protective factor against posttransplantation diabetes mellitus?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN;
HLA DR ANTIGEN;
HLA DR26 ANTIGEN;
HLA DR52 ANTIGEN;
HLA DR6 ANTIGEN;
HLA DR8 ANTIGEN;
IMMUNOSUPPRESSIVE AGENT;
INSULIN;
ORAL ANTIDIABETIC AGENT;
PREDNISOLONE;
UNCLASSIFIED DRUG;
ARTICLE;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DIABETES MELLITUS;
DOSE RESPONSE;
FEMALE;
GENDER;
HEREDITY;
HLA SYSTEM;
HUMAN;
IMMUNITY;
IMMUNOSUPPRESSIVE TREATMENT;
INSULIN TREATMENT;
KIDNEY ALLOGRAFT;
KIDNEY MASS;
MAJOR CLINICAL STUDY;
MALE;
PHENOTYPE;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE PERIOD;
POSTTRANSPLANTATION DIABETES MELLITUS;
PREVALENCE;
PRIORITY JOURNAL;
RECIPIENT;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
RISK FACTOR;
SEX RATIO;
BODY WEIGHT;
DIABETES MELLITUS;
FEMALE;
HLA-DR6 ANTIGEN;
HUMANS;
INCIDENCE;
KIDNEY TRANSPLANTATION;
MALE;
MEDICAL RECORDS;
POSTOPERATIVE COMPLICATIONS;
PREDNISOLONE;
RETROSPECTIVE STUDIES;
RISK FACTORS;
|
EID: 26444613340
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.08.008 Document Type: Article |
Times cited : (5)
|
References (13)
|